Programme: Bioscience – Groundbreaking Research & Diagnostics

Stockholm, November 7^th

 

^{Please note that changes to the programme may occur. Any changes will be reflected here. Stay up to date by revisiting this page before the event.}

---

 

08:00                 Registration, partnering meetings and networking in the exhibition hall

08:55                 Welcome and introduction                           

                                 Johan Rockberg,  Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

 

09:00                 Creating a fertile soil for clinical research at Karolinska University Hospital

                                 Olof Akre, Professor of Cancer Surgery & Director of research, education, and development, Karolinska University Hospital

 

09:25                 Toward person-centric molecular health perspectives

                                 Jochen Schwenk, Professor of Translational Proteomics, KTH Royal Institute of Technology

 

09:50                 Antibodies work in teams:
                           Enhancing the natural phenomenon of IgG hexamerization to drive antibody effector functions

                                 Esther Breij, Vice President, Global Head of Translational Research, Genmab

 

10:15                 Coffee, partnering meetings and networking in the exhibition hall

 

10:55                 Decode and target the non-random metastatic behaviors of adult and childhood cancer

                                 Catharina Hagerling, Associate Professor of Experimental Pathology, Lund University

 

11:20                 How to build an R&D organization with a diverse CNS drug discovery pipeline

                                 Pontus Forsell, Co-founder & Head of Discovery and Research, AlzeCure Pharma

 

11:45                 Lunch, partnering meetings and networking in the exhibition hall 

 

12:45                 Unlocking the potential of academia-industry collaboration

                                 Fadwa Benkessou, PhD, Academia-Industry Alliance Manager, Karolinska Institutet

 

13:10                 Body's own defenses shape virus tropism in the brain

                                 Anna Överby Wernstedt, Professor of Immunology, Umeå University

 

13:35                 Synthetic glycopolymers target primary haemostasis: therapeutic potential in bleeding disorders

                                 Magnus Grenegård, Professor in Physiology, Örebro University

 

14:00                 Coffee, partnering meetings and networking in the exhibition hall

 

14:40                 Intrinsic Activated Thrombin generation assays for evaluation of the haemostatic system:
                           Efficacy and monitoring of different Hemophilia A replacement therapies

                                 Henri M.H. Spronk, PhD, CEO, Coagulation Profile

 

15:05                 A human pan-disease blood atlas based on next generation blood profiling

                                 Mathias Uhlén, Professor of Microbiology, Science for Life Laboratory, KTH Royal Institute of Technology

 

15:30                 To be announced shortly

 

15:55                 Summary and conclusion

                                 Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

 

16:00                 End of programme